Actively informing patients about medicines

Actively informing patients about medicines

For patients, relatives and carers there is no proactive communication about new medicine options or updates on the medicines we take everyday. The consequence is that, whilst we are encouraged to engage more in the management of our healthcare, we are unable to access the information that could improve the debate with healthcarers about the decisions that are, essentially, made for us. Moreover safety information is siloed and there is no efficient mechanism to update consumers about adverse events, new indications, warnings etc.

This has led us to develop Keep Me Informed | Medicines. It is a personalised service that enables individuals to be kept up-to-date on developments about medicines for the conditions they are interested in.

Keep Me Informed | Medicines links information reported by the regulators, HTA organisations, and healthcare providers to information about conditions. Users are notified by email when new information is released so we can inform about new medicines, new indications, safety updates and host of other issues.

We will shortly be making Keep Me Informed | Medicines open access and will use social media as a means of engagement. We will also implement our Medicine Tracker that enables patients to identify specific medicines they are interested in so the personalisation becomes more, personal. Beyond this we will be implementing interaction, contraindication and symptom driven side effect reporting functionality.

How can you help us? We are currently 'soft launching' Keep Me Informed | Medicines, listening to feedback and suggestions and would welcome input from all interested parties - patients, healthcarers, regulators, patient organisations, researchers and pharmaceutical companies - to explore and comment on our ambition.

For more information please contact Steve Mott at [email protected] and visit our website to try Keep Me Informed | Medicines for yourselves.

Link to Keep Me Informed | Medicines

要查看或添加评论,请登录

Stephen Mott的更多文章

社区洞察

其他会员也浏览了